During the past decade, Oncology Hematology Associates of Northern Pennsylvania conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 9 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Hematology Associates of Northern Pennsylvania" #1 collaborator was "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Oncology Hematology Associates of Northern Pennsylvania" are "Breast Adenocarcinoma" (2 trials), "HER2/Neu Positive" (2 trials), "Progesterone Receptor Positive" (2 trials), "Recurrent Breast Carcinoma" (2 trials) and "Stage IA Breast Cancer AJCC v7" (2 trials). Many other conditions were trialed in "Oncology Hematology Associates of Northern Pennsylvania" in a lesser frequency.

Most popular intervention types in "Oncology Hematology Associates of Northern Pennsylvania" are "Other" (11 trials), "Drug" (10 trials), "Biological" (7 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Paclitaxel" (5 trials), "Quality-of-Life Assessment" (5 trials), "Bevacizumab" (4 trials) and "Doxorubicin Hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Hematology Associates of Northern Pennsylvania" are 7 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Oncology Hematology Associates of Northern Pennsylvania". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Oncology Hematology Associates of Northern Pennsylvania, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Hematology Associates of Northern Pennsylvania, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".